New Science Ventures (NSV) is a venture capital firm established in 2004, specializing in investments that leverage breakthrough science to create significant value. With over $900 million in assets under management, NSV focuses on companies in the life sciences and information technology sectors that utilize novel scientific approaches to address substantial market needs. The firm operates from its headquarters in Connecticut and maintains an office in London.